Bionic-engineered tissues have been proposed for testing the performance of cardiovascular medical devices and predicting clinical outcomes ex vivo. Progress has been made in the development of compliant electronics that are capable of monitoring treatment parameters and being coupled to engineered tissues; however, the scale of most engineered tissues is too small to accommodate the size of clinical-grade medical devices. Here, we show substantial progress toward bionic tissues for evaluating cardiac ablation tools by generating a centimeter-scale human cardiac disk and coupling it to a hydrogel-based soft-pressure sensor. The cardiac tissue with contiguous electromechanical function was made possible by our recently established method to ...
In the past few years, microfluidic-based technology has developed microscale models recapitulating ...
An epicardial bioelectronic patch is an important device for investigating and treating heart diseas...
Background: Cardiomyocytes derived from pluripotent stem cells are immature. Maturation of cardiomyo...
Drug-induced cardiotoxicity is regarded as a major hurdle in the early stages of drug development. A...
Biomedical research has relied on animal studies and conventional cell cultures for decades. Recentl...
Purpose of reviewBioengineering of functional cardiac tissue composed of primary cardiomyocytes has ...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
An engineered heart tissue (EHT) derived from human induced pluripotent stem cells (hiPSCs) allows t...
Tissue engineering and cell-based therapies have been recently proposed as promising cure of disease...
There are the growing interests in microphysiological systems (MPS), also known as organs-on-chips, ...
Cardiotoxicity is a major cause of drug failure at the late stages of clinical trials and it is link...
Each year, over one million people in the United States have a myocardial infarction (MI). After an ...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
The high death toll of cardiovascular diseases worldwide and the lack of effective treatments for th...
The role of a biomedical engineer is to solve unmet health-related needs that face society. For the ...
In the past few years, microfluidic-based technology has developed microscale models recapitulating ...
An epicardial bioelectronic patch is an important device for investigating and treating heart diseas...
Background: Cardiomyocytes derived from pluripotent stem cells are immature. Maturation of cardiomyo...
Drug-induced cardiotoxicity is regarded as a major hurdle in the early stages of drug development. A...
Biomedical research has relied on animal studies and conventional cell cultures for decades. Recentl...
Purpose of reviewBioengineering of functional cardiac tissue composed of primary cardiomyocytes has ...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
An engineered heart tissue (EHT) derived from human induced pluripotent stem cells (hiPSCs) allows t...
Tissue engineering and cell-based therapies have been recently proposed as promising cure of disease...
There are the growing interests in microphysiological systems (MPS), also known as organs-on-chips, ...
Cardiotoxicity is a major cause of drug failure at the late stages of clinical trials and it is link...
Each year, over one million people in the United States have a myocardial infarction (MI). After an ...
Cardiomyocytes derived from human pluripotent stem cells (hPSC-CMs) hold a great potential as human ...
The high death toll of cardiovascular diseases worldwide and the lack of effective treatments for th...
The role of a biomedical engineer is to solve unmet health-related needs that face society. For the ...
In the past few years, microfluidic-based technology has developed microscale models recapitulating ...
An epicardial bioelectronic patch is an important device for investigating and treating heart diseas...
Background: Cardiomyocytes derived from pluripotent stem cells are immature. Maturation of cardiomyo...